Corcept Therapeutics Incorporated

Corcept Therapeutics is a biotechnology company that develops drugs to treat disorders related to excess cortisol, a hormone the body naturally produces. The company sells Korlym, a pill for patients with Cushing's syndrome (a rare condition caused by too much cortisol) who also have diabetes or blood sugar problems and cannot have surgery. Corcept is also testing other cortisol-blocking drugs in clinical trials for conditions including fatty liver disease and Lou Gehrig's disease.